Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.0111
0.00 (0.00%)
At close: Mar 3, 2026
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 2 employees as of December 31, 2024. The number of employees decreased by 5 or -71.43% compared to the previous year.
Employees
2
Change (1Y)
-5
Growth (1Y)
-71.43%
Revenue / Employee
n/a
Profits / Employee
-$6,033,613
Market Cap
13.79K
Employees Chart
Virpax Pharmaceuticals News
- 1 year ago - Virpax Pharmaceuticals Announces Reverse Stock Split - Business Wire
- 1 year ago - Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND - Business Wire
- 1 year ago - Virpax Looking to Use MET to Develop Intranasal COVID Vaccine - Business Wire
- 1 year ago - Virpax's NES100 to be Presented at The Society of Toxicology by NCATS - Business Wire
- 1 year ago - Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology - Business Wire
- 1 year ago - Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate - Benzinga
- 1 year ago - Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study - Business Wire
- 1 year ago - Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference - Business Wire